In a resource-constrained setting like Bangladesh, what proportion of a hospital's capacity is taken up with admissions for respiratory syncytial virus (RSV)? How many children needing admission are turned away every year because of lack of bed space? And how many of these "denials" and subsequent deaths might be prevented by the introduction of a maternal RSV vaccine or the monoclonal antibody nirsevimab? 

Listen to Senjuti Saha, Deputy Executive Director of the Child Health Research Foundation, describe the results of her fascinating and potentially policy-changing study to our Editor-in-Chief, Zoë Mullan.

Read the full article:

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(25)00048-8/fulltext?dgcid=buzzsprout_icw_podcast_May_25_langlo

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv